Cargando…

Non-Nucleoside Agonists of the Adenosine Receptors: An Overview

Potent and selective adenosine receptor (AR) agonists are of pharmacological interest for the treatment of a wide range of diseases and conditions. Among these derivatives, nucleoside-based agonists represent the great majority of molecules developed and reported to date. However, the limited availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Ben, Diego, Lambertucci, Catia, Buccioni, Michela, Martí Navia, Aleix, Marucci, Gabriella, Spinaci, Andrea, Volpini, Rosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958362/ https://www.ncbi.nlm.nih.gov/pubmed/31597388 http://dx.doi.org/10.3390/ph12040150

Ejemplares similares

Combined Therapy of A(1)AR Agonists and A(2A)AR Antagonists in Neuroinflammation
por: Marucci, Gabriella, et al.
Publicado: (2021)

Adenosine Receptors as Neuroinflammation Modulators: Role of A(1) Agonists and A(2A) Antagonists
por: Martí Navia, Aleix, et al.
Publicado: (2020)

A(3) Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
por: Spinaci, Andrea, et al.
Publicado: (2022)

Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A(2B) adenosine receptor
por: Dal Ben, Diego, et al.
Publicado: (2013)

P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications
por: Spinaci, Andrea, et al.
Publicado: (2021)

Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A(2A) Adenosine Receptor Useful in Neurodegenerative Disorders
por: Francucci, Beatrice, et al.
Publicado: (2023)

The possible role of the nucleoside adenosine in countering skin aging: A review
por: Marucci, Gabriella, et al.
Publicado: (2022)

A(2A) Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
por: Spinaci, Andrea, et al.
Publicado: (2022)

The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A(3) Receptor Agonist, in a Rat Model of Colitis
por: Antonioli, Luca, et al.
Publicado: (2020)

“Dual Anta-Inhibitors” of the A(2A) Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
por: Spinaci, Andrea, et al.
Publicado: (2023)

Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines
por: Buccioni, Michela, et al.
Publicado: (2014)

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A(1) and A(2A) Receptors, and Efficacy in Animal Models of Depression
por: Varano, Flavia, et al.
Publicado: (2021)

Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligands
por: Dal Ben, Diego, et al.
Publicado: (2006)

Erratum to: Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A(3) adenosine receptor ligands
por: Dal Ben, Diego, et al.
Publicado: (2006)

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile
por: Lambertucci, Catia, et al.
Publicado: (2007)

Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A(1) Receptor Ligands
por: Zuccarini, Mariachiara, et al.
Publicado: (2021)

Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A(2A) adenosine receptor binding site
por: Matricon, Pierre, et al.
Publicado: (2017)

2- and 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosine receptors
por: Volpini, Rosaria, et al.
Publicado: (2005)

Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
por: Dal Ben, Diego, et al.
Publicado: (2018)

Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors. Ranging from Pan Ligands to Combined A1/A2B Partial Agonists
por: Catarzi, Daniela, et al.
Publicado: (2019)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Synthesis and Ability of New Ligands for G Protein-Coupled Receptors 17 (GPR17)
por: Zhuo, Tongyou, et al.
Publicado: (2017)

Purine (N)-Methanocarba Nucleoside Derivatives Lacking an Exocyclic Amine as Selective A(3) Adenosine Receptor Agonists
por: Tosh, Dilip K., et al.
Publicado: (2016)

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A(2A) Adenosine Receptor
por: Shiriaeva, Anna, et al.
Publicado: (2022)

Nucleoside conjugates of quantum dots for characterization of G protein-coupled receptors: strategies for immobilizing A(2A )adenosine receptor agonists
por: Das, Arijit, et al.
Publicado: (2010)

Physiology and effects of nucleosides in mice lacking all four adenosine receptors
por: Xiao, Cuiying, et al.
Publicado: (2019)

Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
por: Klutz, Athena M, et al.
Publicado: (2008)

4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives
por: Catarzi, Daniela, et al.
Publicado: (2022)

The Role of Adenosine Receptor Agonists in Regulation of Hematopoiesis
por: Hofer, Michal, et al.
Publicado: (2011)

Overview of mixed EW-QCD corrections for Drell-Yan
por: Buccioni, Federico, et al.
Publicado: (2022)

Adenosine Deaminase, Nucleoside Phosphorylase and Xanthine Oxidase in Liver Tumours
por: Reid, E., et al.
Publicado: (1957)

Clearance of rapid adenosine release is regulated by nucleoside transporters and metabolism
por: Nguyen, Michael D., et al.
Publicado: (2015)

A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development
por: Jones, Karlie R., et al.
Publicado: (2017)

Overview of Biologically Active Nucleoside Phosphonates
por: Groaz, Elisabetta, et al.
Publicado: (2021)

Anti-Inflammatory Preconditioning by Agonists of Adenosine A1 Receptor
por: Nakav, Sigal, et al.
Publicado: (2008)

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
por: Jacobson, Kenneth A., et al.
Publicado: (2019)

Synthesis and Anti-Renal Fibrosis Activity of Conformationally Locked Truncated 2-Hexynyl-N(6)-Substituted-(N)-Methanocarba-nucleosides as A(3) Adenosine Receptor Antagonists and Partial Agonists
por: Nayak, Akshata, et al.
Publicado: (2014)

Recent improvements in the development of A(2B) adenosine receptor agonists
por: Baraldi, Pier Giovanni, et al.
Publicado: (2008)

C2‐linked alkynyl poly‐ethylene glycol(PEG) adenosine conjugates as water‐soluble adenosine receptor agonists
por: Ferguson, Lindsay, et al.
Publicado: (2022)

Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium: Role of Ectonucleotidases and Adenosine A(2B) Receptors
por: Eltzschig, Holger K., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_923cn90c7a64ja5q90ak52h90u